Cargando…

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT

BACKGROUND: Cryopreservation of PBMC and/or overnight shipping of samples are required for many clinical trials, despite their potentially adverse effects upon immune monitoring assays such as MHC-peptide tetramer staining, cytokine flow cytometry (CFC), and ELISPOT. In this study, we compared the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maecker, Holden T, Moon, James, Bhatia, Sonny, Ghanekar, Smita A, Maino, Vernon C, Payne, Janice K, Kuus-Reichel, Kristine, Chang, Jennie C, Summers, Amanda, Clay, Timothy M, Morse, Michael A, Lyerly, H Kim, DeLaRosa, Corazon, Ankerst, Donna P, Disis, Mary L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190174/ https://www.ncbi.nlm.nih.gov/pubmed/16026627 http://dx.doi.org/10.1186/1471-2172-6-17

Ejemplares similares

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
por: Maecker, Holden T, et al.
Publicado: (2008)

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors
por: Ghanekar, Smita A, et al.
Publicado: (2007)

Performance of plate-based cytokine flow cytometry with automated data analysis
por: Suni, Maria A, et al.
Publicado: (2003)

Optimizing the cryopreservation of murine splenocytes for improved antigen-specific T cell function in ELISPOT
por: Gad, Ekram, et al.
Publicado: (2013)

Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses
por: Goodell, Vivian, et al.
Publicado: (2007)

Immune monitoring technology primer: flow and mass cytometry
por: Maecker, Holden T., et al.
Publicado: (2015)

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
por: Kuerten, Stefanie, et al.
Publicado: (2012)

Full spectrum flow cytometry and mass cytometry: A 32‐marker panel comparison
por: Jaimes, Maria C., et al.
Publicado: (2022)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

VACUTAINER(® )CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples
por: Ruitenberg, Joyce J, et al.
Publicado: (2006)

Detection of Low Abundance RNA Molecules in Individual Cells by Flow Cytometry
por: Hanley, Mary Beth, et al.
Publicado: (2013)

Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses
por: Liao, John B, et al.
Publicado: (2014)

Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays
por: Hagen, Jodi, et al.
Publicado: (2015)

Comparison of Whole Blood Cryopreservation Methods for Extensive Flow Cytometry Immunophenotyping
por: Serra, Valentina, et al.
Publicado: (2022)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Dynamics of the Acetylcholinesterase Tetramer
por: Gorfe, Alemayehu A., et al.
Publicado: (2008)

Standardization of cytokine flow cytometry assays
por: Maecker, Holden T, et al.
Publicado: (2005)

Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
por: Hill, Philip C, et al.
Publicado: (2007)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
por: Kalyuzhny, Alexander E.
Publicado: (2011)

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients
por: Xu, Yuanxin, et al.
Publicado: (2008)

Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control
por: Cai, Yihua, et al.
Publicado: (2021)

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
por: Aiken, Alexander M, et al.
Publicado: (2006)

High Reproducibility of ELISPOT Counts from Nine Different Laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2015)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy
por: Nair, Nitya, et al.
Publicado: (2015)

Identification of platelet subpopulations in cryopreserved platelet components using multi-colour imaging flow cytometry
por: Johnson, Lacey, et al.
Publicado: (2023)

Mass Cytometry Defines Virus-Specific CD4(+) T Cells in Influenza Vaccination
por: Subrahmanyam, Priyanka B., et al.
Publicado: (2020)

The formation pathway of i-motif tetramers
por: Leroy, Jean-Louis
Publicado: (2009)

A Heterospecific Leucine Zipper Tetramer
por: Deng, Yiqun, et al.
Publicado: (2008)

Molecular structure of soluble vimentin tetramers
por: Vermeire, Pieter-Jan, et al.
Publicado: (2023)

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories
por: Gill, Dilbinder K., et al.
Publicado: (2010)

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis
por: Sibley, Laura S., et al.
Publicado: (2012)

Defining ELISpot cut-offs from unreplicated test and control wells
por: Alexander, Neal, et al.
Publicado: (2013)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
por: Zitzner, Jennifer R., et al.
Publicado: (2012)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
por: Anthony, Donald D., et al.
Publicado: (2012)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
por: Janetzki, Sylvia, et al.
Publicado: (2014)

How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
por: Lima-Junior, Josué da Costa, et al.
Publicado: (2017)

Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients
por: Zver, Tristan, et al.
Publicado: (2022)

Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials
por: Abrecht, Charlotte, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ac2b5muo5rrtucqotp2hm0ckj0